Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Anorexia 5Neoplasms 4Weight Loss 2Pancreatic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Cachexia 2Breast Neoplasms 2Sleep Initiation and Maintenance Disorders 1Neoplasm Metastasis 1Malnutrition 1Lung Neoplasms 1Head and Neck Neoplasms 1Depressive Disorder, Major 1Depression 1Body Weight 1Anorexia Nervosa with Significantly Low Body Weight 1Advanced Cancer 1

Interventions

Trastuzumab 628Paclitaxel 577Cyclophosphamide 555Docetaxel 485Capecitabine 402Letrozole 376Fulvestrant 327Doxorubicin 294Carboplatin 279Tamoxifen 275Anastrozole 243exemestane 228Radiotherapy 218Epirubicin 211Bevacizumab 196palbociclib 189pertuzumab 186Vinorelbine 167Lapatinib 167Gemcitabine 166pembrolizumab 162Surveys and Questionnaires 139Exercise 136Magnetic Resonance Spectroscopy 123Fluorouracil 119Blood Specimen Collection 118eribulin 117Albumin-Bound Paclitaxel 117Drug Therapy 111130-nm albumin-bound paclitaxel 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × Mirtazapine × Clear all
NCT06499090 2026-01-22

Mirtazapine for Acute and Chronic Post Mastectomy Pain

Assiut University

Phase EARLY_PHASE1 Completed
62 enrolled
Breast

Breast Neoplasms

NCT02336750 2022-04-20

Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis

Fudan University

Phase 3 Completed
212 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡